10 20 30 40 50 60 70 80 1W76 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 30-AUG-04 1W76
TITLE ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA TITLE 2 ACETYLCHOLINESTERASE (ACHE) COMPLEXED WITH BIS-ACTING TITLE 3 GALANTHAMINE DERIVATIVE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 22-564; COMPND 5 SYNONYM: ACHE; COMPND 6 EC: 3.1.1.7
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787; SOURCE 5 VARIANT: G2 FORM; SOURCE 6 ORGAN: ELECTRIC ORGAN; SOURCE 7 TISSUE: ELECTROPLAQUE
KEYWDS ALZHEIMER'S DISEASE, CHOLINESTERASE, GLYCOPROTEIN, GPI- KEYWDS 2 ANCHOR, HYDROLASE, MUSCLE, NERVE, NEUROTRANSMITTER KEYWDS 3 DEGRADATION, SERINE ESTERASE, SERINE HYDROLASE, SIGNAL, KEYWDS 4 SYNAPSE
EXPDTA X-RAY DIFFRACTION
AUTHOR H.M.GREENBLATT,C.GUILLOU,D.GUENARD,B.BADET,C.THAL,I.SILMAN, AUTHOR 2 J.L.SUSSMAN
REVDAT 2 24-FEB-09 1W76 1 VERSN REVDAT 1 25-NOV-04 1W76 0
JRNL AUTH H.M.GREENBLATT,C.GUILLOU,D.GUENARD,A.ARGAMAN, JRNL AUTH 2 S.BOTTI,B.BADET,C.THAL,I.SILMAN,J.L.SUSSMAN JRNL TITL THE COMPLEX OF A BIVALENT DERIVATIVE OF JRNL TITL 2 GALANTHAMINE WITH TORPEDO ACETYCHOLINESTERASE JRNL TITL 3 DISPLAYS DRASTIC DEFORMATION OF THE ACTIVE-SITE JRNL TITL 4 GORGE: IMPLICATIONS FOR STRUCTURE-BASED DRUG JRNL TITL 5 DESIGN JRNL REF J.AM.CHEM.SOC. V. 126 15405 2004 JRNL REFN ISSN 0002-7863 JRNL PMID 15563167 JRNL DOI 10.1021/JA0466154
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.MARY,D.Z.RENKO,C.GUILLOU,C.THAL REMARK 1 TITL POTENT ACETYLCHOLINESTERASE INHIBITORS: DESIGN, REMARK 1 TITL 2 SYNTHESIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF REMARK 1 TITL 3 BIS-INTERACTING LIGANDS IN THE GALANTHAMINE SERIES REMARK 1 REF BIOORG.MED.CHEM. V. 6 1835 1998 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 9839013 REMARK 1 DOI 10.1016/S0968-0896(98)00133-3
REMARK 2 REMARK 2 RESOLUTION. 2.3 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1695038.47 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 63894 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 3188 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7459 REMARK 3 BIN R VALUE (WORKING SET) : 0.357 REMARK 3 BIN FREE R VALUE : 0.395 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.5 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 431 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8238 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 115 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.5 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.54 REMARK 3 B22 (A**2) : 24.61 REMARK 3 B33 (A**2) : -14.07 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.47 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 1.8 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24. REMARK 3 IMPROPER ANGLES (DEGREES) : 1.23 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.30 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.10 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.68 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.25 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.3497 REMARK 3 BSOL : 33.0197 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: PHTHALIMIDE AND LINKER GROUP NOT REMARK 3 VISIBLE FOR INHIBITORS IN EITHER ACTIVE SITE OF ASYMMETRIC REMARK 3 UNIT. PROTEIN RESIDUES 284-289, PART OF ACTIVE SITE, HAVE REMARK 3 LITTLE OR NO ELECTRON DENSITY IN BOTH CHAINS.
REMARK 4 REMARK 4 1W76 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-AUG-04. REMARK 100 THE PDBE ID CODE IS EBI-20916.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGEPLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63928 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: ISOMORPHOUS TO NATIVE ORTHORHOMBIC FORM
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 35-40% W/V PEG 200, REMARK 280 0.1M MES PH5.8 4 DEG. CELSIUS
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 45.61150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.27950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.62650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.27950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.61150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.62650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 HIS A 3 REMARK 465 PHE A 284 REMARK 465 ASP A 285 REMARK 465 SER A 286 REMARK 465 ILE A 287 REMARK 465 PHE A 288 REMARK 465 ARG A 289 REMARK 465 HIS A 486 REMARK 465 SER A 487 REMARK 465 GLN A 488 REMARK 465 GLU A 489 REMARK 465 ALA A 536 REMARK 465 CYS A 537 REMARK 465 ASP A 538 REMARK 465 GLY A 539 REMARK 465 GLU A 540 REMARK 465 LEU A 541 REMARK 465 SER A 542 REMARK 465 SER A 543 REMARK 465 ASP B 1 REMARK 465 ASP B 2 REMARK 465 HIS B 3 REMARK 465 PHE B 284 REMARK 465 ASP B 285 REMARK 465 SER B 286 REMARK 465 ILE B 287 REMARK 465 PHE B 288 REMARK 465 ARG B 289 REMARK 465 HIS B 486 REMARK 465 SER B 487 REMARK 465 GLN B 488 REMARK 465 GLU B 489 REMARK 465 ALA B 536 REMARK 465 CYS B 537 REMARK 465 ASP B 538 REMARK 465 GLY B 539 REMARK 465 GLU B 540 REMARK 465 LEU B 541 REMARK 465 SER B 542 REMARK 465 SER B 543
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 42 CG OD1 ND2 REMARK 470 ARG A 46 CZ NH1 NH2 REMARK 470 LYS A 192 CE NZ REMARK 470 ARG A 250 CZ NH1 NH2 REMARK 470 GLU A 260 OE1 OE2 REMARK 470 GLU A 268 OE1 OE2 REMARK 470 GLU A 344 OE1 OE2 REMARK 470 GLU A 350 OE1 OE2 REMARK 470 LYS A 357 NZ REMARK 470 ASP A 365 OD1 OD2 REMARK 470 LYS A 413 CD CE NZ REMARK 470 LYS A 498 CG CD CE NZ REMARK 470 GLU A 508 CD OE1 OE2 REMARK 470 ARG A 515 CZ NH1 NH2 REMARK 470 GLN A 526 OE1 NE2 REMARK 470 ASN B 42 CG OD1 ND2 REMARK 470 ARG B 46 CZ NH1 NH2 REMARK 470 ARG B 250 CZ NH1 NH2 REMARK 470 ASN B 257 CG OD1 ND2 REMARK 470 GLU B 260 OE1 OE2 REMARK 470 GLU B 268 OE1 OE2 REMARK 470 GLU B 344 OE1 OE2 REMARK 470 GLU B 350 OE1 OE2 REMARK 470 LYS B 357 NZ REMARK 470 ASP B 365 OD1 OD2 REMARK 470 LYS B 413 CD CE NZ REMARK 470 LYS B 498 CG CD CE NZ REMARK 470 ARG B 515 CZ NH1 NH2 REMARK 470 GLN B 526 OE1 NE2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 518 CB - CA - C ANGL. DEV. = -12.2 DEGREES REMARK 500 PRO B 361 C - N - CA ANGL. DEV. = 10.3 DEGREES REMARK 500 LYS B 491 N - CA - C ANGL. DEV. = 17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -166.46 177.35 REMARK 500 PHE A 45 -11.74 83.05 REMARK 500 GLU A 73 42.59 -141.16 REMARK 500 SER A 108 67.91 -157.59 REMARK 500 ALA A 164 65.57 -151.46 REMARK 500 SER A 200 -112.80 57.20 REMARK 500 ASN A 253 72.41 50.52 REMARK 500 ASN A 280 7.91 -66.89 REMARK 500 THR A 317 -159.46 -162.29 REMARK 500 ASP A 326 69.85 -116.05 REMARK 500 ASP A 380 48.53 -159.01 REMARK 500 ALA A 427 136.88 -39.98 REMARK 500 LYS A 498 -73.26 -83.60 REMARK 500 ARG A 517 46.68 38.00 REMARK 500 SER B 25 -168.20 -171.16 REMARK 500 PHE B 45 -9.62 88.82 REMARK 500 SER B 108 73.98 -151.41 REMARK 500 LEU B 158 71.66 -119.11 REMARK 500 ALA B 164 70.33 -158.84 REMARK 500 SER B 200 -120.63 59.88 REMARK 500 LEU B 211 -74.78 -77.22 REMARK 500 SER B 212 114.34 -35.57 REMARK 500 ASN B 280 0.99 -65.84 REMARK 500 GLU B 299 -71.35 -125.48 REMARK 500 THR B 317 -157.54 -153.36 REMARK 500 ASP B 326 65.86 -117.76 REMARK 500 ASP B 380 56.85 -144.84 REMARK 500 GLN B 526 -60.23 -101.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 442 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LYS A 491 24.8 L L OUTSIDE RANGE REMARK 500 LYS B 491 23.3 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED.
REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A1536 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A1537 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B1536 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B1537 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNT A1538 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNT B1538
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ACJ RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH TACRINE REMARK 900 RELATED ID: 1ACL RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH DECAMETHONIUM REMARK 900 RELATED ID: 1AMN RELATED DB: PDB REMARK 900 TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE REMARK 900 COMPLEXED WITH M-(N,N,N-TRIMETHYLAMMONIO) REMARK 900 TRIFLUOROACETOPHENONE REMARK 900 RELATED ID: 1AX9 RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, REMARK 900 LAUE DATA REMARK 900 RELATED ID: 1CFJ RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) REMARK 900 OBTAINED BY REACTION WITH O- REMARK 900 ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 (-)-GALANTHAMINE AT 2.3A RESOLUTION REMARK 900 RELATED ID: 1E3Q RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH BW284C51 REMARK 900 RELATED ID: 1E66 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 (-)-HUPRINE X AT 2.1A RESOLUTION REMARK 900 RELATED ID: 1EA5 RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7 REMARK 900 ) FROM TORPEDO CALIFORNICA AT 1.8A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1EEA RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1EVE RELATED DB: PDB REMARK 900 THREE DIMENSIONAL STRUCTURE OF THE ANTI- REMARK 900 ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED REMARK 900 WITH ITS TARGET ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN- REMARK 900 II REMARK 900 RELATED ID: 1GPK RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH REMARK 900 (+)-HUPERZINE A AT 2.1A RESOLUTION REMARK 900 RELATED ID: 1GPN RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 HUPERZINE B AT 2.35A RESOLUTION REMARK 900 RELATED ID: 1GQR RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) REMARK 900 COMPLEXED WITH RIVASTIGMINE REMARK 900 RELATED ID: 1GQS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) REMARK 900 COMPLEXED WITH NAP REMARK 900 RELATED ID: 1H22 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH (S,S)-(-)-BIS(10)- REMARK 900 HUPERZINE A-LIKE INHIBITOR AT 2.15A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1H23 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH (S,S)-(-)-BIS(12)- REMARK 900 HUPERZINE A-LIKE INHIBITOR AT 2.15A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1HBJ RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN REMARK 900 TORPEDO CALIFORNICA ACHE AND A REVERSIBLE REMARK 900 INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-( REMARK 900 3-TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE REMARK 900 RELATED ID: 1JGA RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,7- REMARK 900 HEPTYLENE-BIS-N,N'-SYN-2-PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JGB RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,3- REMARK 900 PROPYLENE-BIS-N,N'-SYN-4-PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JJB RELATED DB: PDB REMARK 900 A NEUTRAL MOLECULE IN CATION-BINDING SITE: REMARK 900 SPECIFIC BINDINGOF PEG-SH TO REMARK 900 ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 1OCE RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH MF268 REMARK 900 RELATED ID: 1ODC RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH N-4'-QUINOLYL-N'-9 REMARK 900 "-(1",2",3",4"-TETRAHYDROACRIDINYL)-1,8- REMARK 900 DIAMINOOCTANE AT 2.2A RESOLUTION REMARK 900 RELATED ID: 1QID RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT A) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIE RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT B) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIF RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT C) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIG RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT D) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIH RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT E) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QII RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT F) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIJ RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT G) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIK RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT H) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIM RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT I) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1SOM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED REMARK 900 BY NERVE AGENT GD (SOMAN). REMARK 900 RELATED ID: 1UT6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH N-9-(1',2',3',4 REMARK 900 '-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT REMARK 900 2.4 ANGSTROMS RESOLUTION. REMARK 900 RELATED ID: 1VOT RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A REMARK 900 RELATED ID: 1VXO RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) REMARK 900 OBTAINED BY REACTION WITH O-ETHYL-S-[2-[ REMARK 900 BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1VXR RELATED DB: PDB REMARK 900 O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE REMARK 900 OBTAINED BY REACTION WITH O-ETHYL-S-[2-[ REMARK 900 BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1W4L RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH BIS-ACTING REMARK 900 GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W6R RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W75 RELATED DB: PDB REMARK 900 NATIVE ORTHORHOMBIC FORM OF TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE (ACHE) REMARK 900 RELATED ID: 2ACE RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO REMARK 900 CALIFORNICA REMARK 900 RELATED ID: 2ACK RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, REMARK 900 MONOCHROMATIC DATA REMARK 900 RELATED ID: 2DFP RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF AGED DI-ISOPROPYL- REMARK 900 PHOSPHORO-FLUORIDATE (DFP) BOUND TO REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 3ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (R)-E2020 BOUND REMARK 900 ACETYLCHOLINESTERASE COMPLEX, 3 STRUCTURES REMARK 900 RELATED ID: 4ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (S)-E2020 BOUND REMARK 900 ACETYLCHOLINESTERASE COMPLEX, 3 STRUCTURES
REMARK 999 REMARK 999 SEQUENCE REMARK 999 FIRST THREE RESIDUES IN BOTH CHAINS NOT VISIBLE. LAST 8 REMARK 999 RESIDUES IN BOTH CHAINS NOT VISIBLE. RESIDUES 486-489 NOT REMARK 999 VISIBLE IN CHAIN A, BUT ARE VISIBLE IN CHAIN B.
DBREF 1W76 A 1 543 UNP P04058 ACES_TORCA 22 564 DBREF 1W76 B 1 543 UNP P04058 ACES_TORCA 22 564
SEQRES 1 A 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 A 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 A 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 A 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 A 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 A 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 A 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 A 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 A 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 A 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 A 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 A 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 A 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 A 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 A 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 A 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 A 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 A 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 A 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 A 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 A 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 A 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 A 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 A 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 A 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 A 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 A 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 A 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 A 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 A 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 A 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 A 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 A 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 A 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 A 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 A 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 A 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 A 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 A 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 A 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 A 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 A 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER SEQRES 1 B 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 B 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 B 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 B 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 B 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 B 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 B 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 B 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 B 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 B 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 B 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 B 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 B 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 B 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 B 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 B 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 B 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 B 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 B 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 B 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 B 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 B 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 B 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 B 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 B 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 B 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 B 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 B 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 B 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 B 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 B 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 B 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 B 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 B 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 B 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 B 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 B 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 B 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 B 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 B 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 B 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 B 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER
HET NAG A1536 14 HET NAG A1537 14 HET NAG B1536 14 HET NAG B1537 14 HET GNT A1538 21 HET GNT B1538 21
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM GNT (-)-GALANTHAMINE
HETSYN NAG NAG
FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 7 GNT 2(C17 H21 N O3) FORMUL 9 HOH *115(H2 O1)
HELIX 1 1A SER A 79 ASN A 85 1 7 HELIX 2 2A GLY A 132 GLU A 139 1 8 HELIX 3 3A VAL A 168 ASN A 183 1 16 HELIX 4 4A SER A 200 LEU A 211 1 12 HELIX 5 5A VAL A 238 LEU A 252 1 15 HELIX 6 6A ASP A 259 GLU A 268 1 10 HELIX 7 7A PRO A 271 GLU A 278 1 8 HELIX 8 8A LEU A 305 SER A 311 1 7 HELIX 9 9A SER A 329 GLY A 335 1 7 HELIX 10 10A ARG A 349 VAL A 360 1 12 HELIX 11 11A ASP A 365 THR A 376 1 12 HELIX 12 12A GLY A 384 TYR A 411 1 28 HELIX 13 13A GLU A 443 PHE A 448 1 6 HELIX 14 14A ALA A 460 THR A 479 1 20 HELIX 15 15A VAL A 518 THR A 535 1 18
SHEET 1 A 3 LEU A 6 THR A 10 0 SHEET 2 A 3 GLY A 13 MET A 16 -1 N VAL A 15 O VAL A 8 SHEET 3 A 3 VAL A 57 ALA A 60 1 N TRP A 58 O LYS A 14 SHEET 1 B11 MET A 16 PRO A 21 0 SHEET 2 B11 HIS A 26 PRO A 34 -1 O ALA A 29 N THR A 18 SHEET 3 B11 TYR A 96 PRO A 102 -1 N ILE A 99 O PHE A 30 SHEET 4 B11 VAL A 142 SER A 147 -1 N LEU A 143 O TRP A 100 SHEET 5 B11 THR A 109 TYR A 116 1 N MET A 112 O VAL A 142 SHEET 6 B11 THR A 193 GLU A 199 1 O THR A 195 N VAL A 113 SHEET 7 B11 ARG A 220 SER A 226 1 N ILE A 223 O ILE A 196 SHEET 8 B11 GLN A 318 ASN A 324 1 N GLY A 322 O LEU A 224 SHEET 9 B11 GLY A 417 PHE A 423 1 N TYR A 421 O LEU A 321 SHEET 10 B11 PHE A 502 LEU A 505 1 N ILE A 503 O LEU A 420 SHEET 11 B11 MET A 510 GLN A 514 -1 N HIS A 513 O PHE A 502
SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.04 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.02 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.01 SSBOND 4 CYS B 67 CYS B 94 1555 1555 2.05 SSBOND 5 CYS B 254 CYS B 265 1555 1555 2.02 SSBOND 6 CYS B 402 CYS B 521 1555 1555 2.03
LINK ND2 ASN A 59 C1 NAG A1536 1555 1555 1.46 LINK ND2 ASN A 416 C1 NAG A1537 1555 1555 1.46 LINK ND2 ASN B 59 C1 NAG B1536 1555 1555 1.46 LINK ND2 ASN B 416 C1 NAG B1537 1555 1555 1.46
CISPEP 1 SER A 103 PRO A 104 0 0.32 CISPEP 2 SER B 103 PRO B 104 0 0.69
SITE 1 AC1 2 ASN A 59 SER A 61 SITE 1 AC2 1 ASN A 416 SITE 1 AC3 2 ASN B 59 SER B 61 SITE 1 AC4 2 ASN B 416 HOH B2046 SITE 1 AC5 10 TRP A 84 GLY A 118 GLY A 119 TYR A 121 SITE 2 AC5 10 GLU A 199 SER A 200 PHE A 290 PHE A 331 SITE 3 AC5 10 HIS A 440 HOH A2054 SITE 1 AC6 9 TRP B 84 GLY B 118 TYR B 121 GLU B 199 SITE 2 AC6 9 SER B 200 PHE B 290 PHE B 331 HIS B 440 SITE 3 AC6 9 HOH B2017
CRYST1 91.223 105.253 150.559 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010962 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009501 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006642 0.00000
MTRIX1 1 -0.999970 -0.007140 -0.002930 182.80691 1
MTRIX2 1 -0.007170 0.999920 0.010770 0.04906 1
MTRIX3 1 0.002850 0.010790 -0.999940 102.58550 1